We next examined the mRNA expression level in 3 BRM-deficient and 1 BRM-positive Rhabdoid tumors, as determined by IHC, and observed that the BRM mRNA expression was on average 27±3-fold lower in the BRM-negative Rhabdoid tumors compared to the BRM-positive tumor. Here, SMARCA2 is linked to neoplasm.